These findings elucidate rutin‘s novel therapeutic mechanism through coordinated suppression of the cGAS-STING-NLRP3 axis, positioning it as a promising candidate for ALI/ARDS intervention. The gene discussed is NLRP3; the disease is acute respiratory distress syndrome.